South African GASTROENTEROLOGY Review | Volume 17 Issue 3 2019

• Reduces the signs and symptoms of CD • Induces and maintains clinical remission • Induces mucosal healing REVELLEX ® in moderate to severe CD 1 * • Improves quality of life • Enables patients to reduce or eliminate corticosteroid use